Therapeutic Drug Monitoring · 2017 · 79 citations · 33 references
PharmacyPharmacologyToxicologyAnalytical ChemistryMass Spectrometric AnalysisPharmacodynamicsCannabinoid PharmacologyCannabinoid ToxicologyCannabis ToxicologyMass SpectrometryMetabolite ExtractionMetabolite QuantificationAtmospheric Pressure Chemical Ionization CouplingBlood Cannabinoid AnalysisCannabinoid Analytical ToxicologyCannabinoid BiomarkersCannabinoid DetectionHigh-performance Liquid ChromatographyTandem Mass SpectrometryTandem Mass Spectrometry Analysis
BACKGROUND: Although, especially in the United States, there has been a recent surge of legalized cannabis for either recreational or medicinal purposes, surprisingly little is known about clinical dose-response relationships, pharmacodynamic and toxicodynamic effects of cannabinoids such as Δ9-tetrahydrocannabinol (THC). Even less is known about other active cannabinoids. METHODS: To address this knowledge gap, an online extraction, high-performance liquid chromatography coupled with tandem mass spectrometry method for simultaneous quantification of 11 cannabinoids and metabolites including THC, 11-hydroxy-Δ9-tetrahydrocannabinol, 11-nor-Δ9-tetrahydrocannabinol-9-carboxylic acid, 11-nor-Δ9-tetrahydrocannabinol-9-carboxylic acid glucuronide (THC-C-gluc), cannabinol, cannabidiol, cannabigerol, cannabidivarin, Δ9-tetrahydrocannabivarin (THCV), and 11-nor-9-carboxy-Δ9-tetrahydrocannabivarin (THCV-COOH) was developed and validated in human urine and plasma. RESULTS: In contrast to atmospheric pressure chemical ionization, electrospray ionization was associated with extensive ion suppression in plasma and urine samples. Thus, the atmospheric pressure chemical ionization assay was validated showing a lower limit of quantification ranging from 0.39 to 3.91 ng/mL depending on study compound and matrix. The upper limit of quantification was 400 ng/mL except for THC-C-gluc with an upper limit of quantification of 2000 ng/mL. The linearity was r > 0.99 for all analyzed calibration curves. Acceptance criteria for intrabatch and interbatch accuracy (85%-115%) and imprecision (<15%) were met for all compounds. In plasma, the only exceptions were THCV (75.3%-121.2% interbatch accuracy) and cannabidivarin (interbatch imprecision, 15.7%-17.2%). In urine, THCV did not meet predefined acceptance criteria for intrabatch accuracy. CONCLUSIONS: This assay allows for monitoring not only THC and its major metabolites but also major cannabinoids that are of interest for marijuana research and clinical practice.
33
Mohanraj Rajesh, Partha Mukhopadhyay, Sándor Bátkai et al. · Journal of the American College of Cardiology · 2010 · 490 citations · Full text
Medicine, Cardiology, Pharmacology +17